Efficacy of early stereotactic body radiotherapy to the primary lung lesion in patients with NSCLC harboring sensitive EGFR mutations treated with first-line EGFR-TKIs

被引：0
|
作者：
Tao, D. [1 ]
Lei, H. [2 ]
Tan, J. [1 ]
Yang, D. [1 ]
Jiang, Y. [1 ]
Zhou, W. [1 ]
Wang, Y. [1 ]
Wu, Y. [1 ]
机构：
[1] Chongqing Univ, Dept Radiat Oncol, Canc Hosp, Chongqing, Peoples R China
[2] Chongqing Univ, Chongqing Canc Multi Omics Big Data Applicat Engn, Canc Hosp, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2384
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1351P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Update Phase II Results of Early Primary Tumor Stereotactic Body Radiotherapy Combined with First-Line EGFR-TKI in Advanced EGFR Mutated NSCLC
    Lv, D.
    Xu, H.
    Meng, Y.
    Wang, W.
    Wu, X.
    Kong, F.
    Yang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S395 - S396
  • [42] Monitoring Plasma EGFR Mutations during First Line Treatment with EGFR TKIs in NSCLC Patients
    Mohorcic, Katja
    Kern, Izidor
    Janzic, Urska
    Hitij, Nina Turnsek
    Rot, Mitja
    Cufer, Tanja
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S388 - S389
  • [43] Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy
    Li, Haixia
    Wang, Chenyu
    Wang, Ziqi
    Hu, Yabo
    Zhang, Guowei
    Zhang, Mina
    Zheng, Xuanxuan
    Zhang, Xiaojuan
    Yang, Jinbo
    Ma, Zhiyong
    Wang, Huijuan
    LUNG CANCER, 2019, 130 : 42 - 49
  • [44] Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations
    He, Qihua
    Liu, Jun
    Cai, Xiuyu
    Li, Caichen
    Liang, Hengrui
    Cheng, Bo
    Xia, Xiaojun
    Guo, Minzhang
    Liang, Peng
    Zhong, Ran
    Li, Feng
    Yu, Ziwen
    Zhao, Yi
    Ou, Limin
    Xiong, Shan
    Li, Jianfu
    Zhang, Jianrong
    He, Jianxing
    Liang, Wenhua
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (11) : 4120 - +
  • [45] Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations
    Chen, Dan
    Song, Zhengbo
    Cheng, Guoping
    ONCOTARGETS AND THERAPY, 2016, 9 : 4181 - 4186
  • [46] Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations
    Liang, W.
    He, Q.
    Li, C.
    Liang, H.
    Cheng, B.
    He, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S732 - S732
  • [47] Rare and Common EGFR Mutations in Patients with Advanced NSCLC Treated with EGFR-TKIs: A Registry-Based Study
    Pesek, Milos
    Kolek, Vitezslav
    Skrickova, Jana
    Cernovska, Marketa
    Koubkova, Leona
    Roubec, Jaromir
    Salajka, Frantisek
    Zemanova, Milada
    Krejci, Jana
    Hejduk, Karel
    Ryska, Ales
    Minarik, Marek
    Fiala, Ondrej
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [48] First-line gefitinib for elderly patients harboring EGFR mutations
    Asami, K.
    Koizumi, T.
    Amejima, S.
    Morikawa, A.
    Morozumi, N.
    Hirai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] THE CONCOMITANT GENE ALTERATIONS IMPACT THE THERAPEUTIC EFFICACY OF EGFR-TKIS IN ADVANCED NSCLC PATIENTS WITH EGFR SENSITIVE MUTATION
    Chang, Cheng-Yu
    Chang, Shih-Chieh
    Lai, Jiun-I
    Lai, Yi-Chun
    RESPIROLOGY, 2019, 24 : 272 - 272
  • [50] Co-occurring genetic alterations predict distant metastasis and poor efficacy of first-line EGFR-TKIs in EGFR-mutant NSCLC
    Li-Li Deng
    Ge Gao
    Hong-Bin Deng
    Feng Wang
    Zhi-Hui Wang
    Yu Yang
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2613 - 2624
12345